scholarly journals Evaluation of characteristic of human turbinate derived mesenchymal stem cells cultured in the serum free media

PLoS ONE ◽  
2017 ◽  
Vol 12 (10) ◽  
pp. e0186249 ◽  
Author(s):  
Se Hwan Hwang ◽  
WeonSun Lee ◽  
Sang Hi Park ◽  
Hee Jin Lee ◽  
Sun Hwa Park ◽  
...  
2012 ◽  
Vol 2012 ◽  
pp. 1-21 ◽  
Author(s):  
Sunghoon Jung ◽  
Krishna M. Panchalingam ◽  
Lawrence Rosenberg ◽  
Leo A. Behie

Human mesenchymal stem cells (hMSCs) are presently being evaluated for their therapeutic potential in clinical studies to treat various diseases, disorders, and injuries. To date, early-phase studies have indicated that the use of both autologous and allogeneic hMSCs appear to be safe; however, efficacy has not been demonstrated in recent late-stage clinical trials. Optimized cell bioprocessing protocols may enhance the efficacy as well as safety of hMSC therapeutics. Classical media used for generating hMSCs are typically supplemented with ill-defined supplements such as fetal bovine serum (FBS) or human-sourced alternatives. Ideally, culture media are desired to have well-defined serum-free formulations that support the efficient production of hMSCs while maintaining their therapeutic and differentiation capacity. Towards this objective, we review here current cell culture media for hMSCs and discuss medium development strategies.


Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 4257-4257 ◽  
Author(s):  
Nathalie Meuleman ◽  
Tatiana Tondreau ◽  
Alain Delforge ◽  
Marielle Dejeneffe ◽  
Martine Massy ◽  
...  

Abstract BACKGROUND: Bone Marrow mesenchymal stem cells (MSC) are pluripotent cells that have the capacity to differentiate into several tissue lineages and also the ability to support hematopoiesis. Their use in gene and cell therapy requires their in vitro expansion. Maintenance and proliferation of MSC are strongly dependent on the culture conditions such as properties of the bovine serum added in the culture medium. However, duration and culture conditions are critical for the successful clinical use of MSC. OBJECTIVE: We have evaluated the efficiency of a commercial serum-free medium (UltraCulture, Bio-Whittaker, Walkersville, MD) supplemented with a serum substitute (Ultroser, BioSepra, Cergy-Saint-Christophe, France) in order to work without FBS and to have a more constant composition. This medium (UC) was compared to the classical medium a-MEM containing 10% FBS (Invitrogen, Merelbeke, Belgium). METHODS: BM-mononuclear cells collected from 11 healthy donors were plated in petri dishes at a concentration of 105/cm2. After 3 days, non adherent cells were removed and culture media were added to adherent cells which were maintained at 37°C until they reached confluence. MSC expansion was analysed after the primoculture (PM) and after the first passage (P1). CFU-F (colony forming units-fibroblastic) number, phenotypic analysis and differentiation potential were also evaluated. RESULTS::The mean culture duration was 13±2 and 8±2 days respectively for PM and P1 but the confluence was reached more rapidly for cells cultured in UC. After PM, 0.35x106 and 1.21x106 cells were obtained for MEM and UC respectively (p<0.005). Moreover, around 20% of cells cultured in MEM were CD45+ while the level of CD45+ cells was frequently < 5% in UC indicating that UC medium favored the rapid elimination of hematopoietic cells. After P1, the expansion rate was significantly higher in UC than MEM: respectively 5.13 ± 1.2 and 22.6 ± 3 (p<0.0005). The numbers of CFU-F were always higher in UC demonstrating the enhanced proliferation in serum-free medium. The phenotype of MSC was similar in the both media: SH2+, SH3+, CD44+, CD45−, CD34−, HLA-DR−. More importantly, these cells remained able to differentiate into osteocytes, chondrocytes, adipocytes and neuron-like cells in the both media confirming their multipotentiality. CONCLUSIONS: Our data strongly support UltraCulture medium supplemented with a serum substitute as an optimal medium for MSC culture. Indeed, it allows a better cell expansion, better proliferation and preserves multipotentiality. This medium, reducing culture period and containing low concentration of serum substitute, is of major interest for clinical production of MSC.


Cytotherapy ◽  
2014 ◽  
Vol 16 (4) ◽  
pp. S111 ◽  
Author(s):  
S.H. Mei ◽  
M. Salkhordeh ◽  
F. Xue ◽  
J. Zhang ◽  
I. Watpool ◽  
...  

2018 ◽  
Vol 9 (1) ◽  
Author(s):  
Maria C. Naskou ◽  
Scarlett M. Sumner ◽  
Anna Chocallo ◽  
Hannah Kemelmakher ◽  
Merrilee Thoresen ◽  
...  

Cytotherapy ◽  
2014 ◽  
Vol 16 (4) ◽  
pp. S70
Author(s):  
Z. Han ◽  
Y. Wang ◽  
Y. Chi ◽  
S. Yan ◽  
A. Mao ◽  
...  

2017 ◽  
Vol 18 (8) ◽  
pp. 1779 ◽  
Author(s):  
Myung-Suk Lee ◽  
Christine Youn ◽  
Jeong Kim ◽  
Byoung Park ◽  
Jongchan Ahn ◽  
...  

2015 ◽  
Vol 12 (2) ◽  
pp. 245-256 ◽  
Author(s):  
Kaitlin C. Clark ◽  
Amir Kol ◽  
Salpi Shahbenderian ◽  
Jennifer L. Granick ◽  
Naomi J. Walker ◽  
...  

2022 ◽  
Author(s):  
Joo Youn Lee ◽  
Min Hee Kang ◽  
Ji Eun Jang ◽  
Jeong Eon Lee ◽  
Yuyeong Yang ◽  
...  

Abstract Stem cells are attractive candidates for the regeneration of tissue and organ. Mesenchymal stem cells (MSCs) have been extensively investigated for their potential applications in regenerative medicine and cell therapy. For developing effective stem cell therapy, the mass production of consistent quality cells is required. The cell culture medium is the most critical aspect of the mass production of qualified stem cells. Classically, fetal bovine serum (FBS) has been used as a culture supplement for MSCs. Due to the undefined and heterologous composition of animal origin components in FBS, efforts to replace animal-derived components with non-animal-derived substances led to safe serum free media (SFM). Adipose derived mesenchymal stem cells (ADSCs) cultivated in SFM provided a more stable population doubling time (PDT) to later passage and more cells in a shorter time compared to FBS containing media. ADSCs cultivated in SFM had lower cellular senescence, lower immunogenicity, and higher genetic stability than ADSCs cultivated in FBS containing media. Differential expression analysis of mRNAs and proteins showed that the expression of genes related with apoptosis, immune response, and inflammatory response were significantly up-regulated in ADSCs cultivated in FBS containing media. ADSCs cultivated in SFM showed similar therapeutic efficacy in an acute pancreatitis mouse model to ADSCs cultivated in FBS containing media. Consideration of clinical trials, not only pre-clinical trial, suggests that cultivation of MSCs using SFM might offer more safe cell therapeutics as well as repeated administration due to low immunogenicity.


2015 ◽  
Vol 9 (Suppl 9) ◽  
pp. P70 ◽  
Author(s):  
Céline Martin ◽  
Alexandre Piccini ◽  
Isabelle Chevalot ◽  
Eric Olmos ◽  
Emmanuel Guedon ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document